M&T BANK CORP - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 366 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.

Quarter-by-quarter ownership
M&T BANK CORP ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$218,161
+3.1%
4,812
-6.7%
0.00%0.0%
Q2 2023$211,690
-8.0%
5,160
-0.2%
0.00%0.0%
Q3 2022$230,000
+12.7%
5,168
-6.1%
0.00%0.0%
Q2 2022$204,000
-71.5%
5,501
-56.7%
0.00%
-66.7%
Q4 2020$717,000
+19.5%
12,700
+0.4%
0.00%0.0%
Q3 2020$600,000
-21.6%
12,654
-2.3%
0.00%
-25.0%
Q2 2020$765,000
+26.9%
12,957
+1.6%
0.00%0.0%
Q1 2020$603,000
-33.7%
12,759
-15.2%
0.00%0.0%
Q4 2019$909,000
+7.8%
15,045
+7.1%
0.00%0.0%
Q3 2019$843,000
-5.4%
14,054
+1.5%
0.00%
-20.0%
Q2 2019$891,000
-8.7%
13,853
+15.2%
0.01%0.0%
Q1 2019$976,000
+54.9%
12,030
+3.2%
0.01%
+25.0%
Q4 2018$630,000
+5.2%
11,661
+0.3%
0.00%
+33.3%
Q3 2018$599,000
+12.6%
11,622
-9.1%
0.00%0.0%
Q2 2018$532,000
-1.5%
12,789
+4.5%
0.00%0.0%
Q1 2018$540,000
-10.9%
12,234
+1.4%
0.00%0.0%
Q4 2017$606,000
-3.5%
12,062
-2.4%
0.00%0.0%
Q3 2017$628,000
+1.8%
12,353
+1.8%
0.00%
-25.0%
Q2 2017$617,000
+21.0%
12,130
-4.3%
0.00%
+33.3%
Q1 2017$510,000
-20.2%
12,676
-5.0%
0.00%
-25.0%
Q4 2016$639,000
+39.5%
13,339
+6.7%
0.00%
+33.3%
Q3 2016$458,000
-2.6%
12,503
+8.2%
0.00%0.0%
Q1 2016$470,000
-41.7%
11,553
-11.3%
0.00%
-40.0%
Q4 2015$806,00013,0220.01%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Tweedy, Browne Co LLC 3,510,173$159,221,4478.52%
Bellevue Group AG 9,233,700$418,840,6326.75%
Deep Track Capital, LP 2,834,069$128,553,3704.96%
BVF INC/IL 4,004,613$181,649,2464.90%
Sicart Associates LLC 203,132$9,214,0683.61%
Camber Capital Management LP 2,250,000$102,0603.36%
Privium Fund Management B.V. 228,493$10,364,4433.08%
Orbimed Advisors 2,169,500$98,408,5202.09%
SECTOR GAMMA AS 165,616$7,512,3421.92%
TANAKA CAPITAL MANAGEMENT INC 14,612$6631.89%
View complete list of IONIS PHARMACEUTICALS INC shareholders